Search Results

Suggested Topics within your search.
Refine Results
  1. 1
    The safety and tolerability of spironolactone in patients with mild to moderate chronic kidney disease

    The safety and tolerability of spironolactone in patients with mild to moderate chronic kidney disease by Nicola C. Edwards, Richard P. Steeds, Colin D. Chue, Paul M. Stewart, Charles J. Ferro, Jonathan N. Townend

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Hormonal regulation of (Na+,K+)-ATPase biosynthesis in the toad bladder. Effect of aldosterone and 3,5,3'-triiodo-L-thyronine.

    Hormonal regulation of (Na+,K+)-ATPase biosynthesis in the toad bladder. Effect of aldosterone and 3,5,3'-triiodo-L-thyronine. by K. Geering, M Girardet, Claude Bron, J P Kraehenbühl, Bernard C. Rossier

    Published 1982
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Spironolactone prevents alterations associated with cardiac hypertrophy produced by isoproterenol in rats: involvement of serum‐ and glucocorticoid‐regulated kinase type 1

    Spironolactone prevents alterations associated with cardiac hypertrophy produced by isoproterenol in rats: involvement of serum‐ and glucocorticoid‐regulated kinase type 1 by Beatriz Martín‐Fernández, Natalia de las Heras, María Miana, Sandra Ballesteros, María Valero‐Muñoz, Dalton Valentim Vassallo, Ana Paula Davel, Luciana Venturini Rossoni, Victoria Cachofeiro, Vicente Lahera

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Effects of spironolactone on atrial structural remodelling in a canine model of atrial fibrillation produced by prolonged atrial pacing

    Effects of spironolactone on atrial structural remodelling in a canine model of atrial fibrillation produced by prolonged atrial pacing by Jingjing Zhao, J Li, W. Li, Y Li, Hong Qu Shan, Yanling Gong, Baofeng Yang

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Early Spironolactone Treatment Attenuates Heart Failure Development by Improving Myocardial Function and Reducing Fibrosis in Spontaneously Hypertensive Rats

    Early Spironolactone Treatment Attenuates Heart Failure Development by Improving Myocardial Function and Reducing Fibrosis in Spontaneously Hypertensive Rats by M. D. M. Cezar, R. L. Damatto, Luana Urbano Pagan, A. R. R. Lima, Paula Felippe Martinez, Camila Bonomo, C. M. Rosa, Dijon Henrique Salomé de Campos, Antônio Carlos Cicogna, Mariana Janini Gomes, S. A. Oliveira, Daniella Audi Blotta, Marina Politi Okoshi, Katashi Okoshi

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    The negative inotropic action of canrenone is mediated by L‐type calcium current blockade and reduced intracellular calcium transients

    The negative inotropic action of canrenone is mediated by L‐type calcium current blockade and reduced intracellular calcium transients by Andréa Rodrigues da Costa, Laila Brito Torres, Emiliano Medei, Rafael A. Ricardo, Jerônimo Pereira de França, Soraya S. Smaili, José Nascimento, Maria E.M. Oshiro, José Wilson Magalhães Bassani, Alice T. Ferreira, Paulo José Ferreira Tucci

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Impact of worsening renal function related to medication in heart failure

    Impact of worsening renal function related to medication in heart failure by Hans‐Peter Brunner‐La Rocca, Christian Knackstedt, Luc W.M. Eurlings, Vinzent Rolny, Friedemann Krause, Matthias Pfisterer, Daniel Tobler, Peter Rickenbacher, Micha T. Maeder

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Finerenone Impedes Aldosterone-dependent Nuclear Import of the Mineralocorticoid Receptor and Prevents Genomic Recruitment of Steroid Receptor Coactivator-1

    Finerenone Impedes Aldosterone-dependent Nuclear Import of the Mineralocorticoid Receptor and Prevents Genomic Recruitment of Steroid Receptor Coactivator-1 by Larbi Amazit, Florian Le Billan, Peter Kolkhof, Khadija Lamribet, Say Viengchareun, Michel Fay, Junaid Khan, Alexander Hillisch, Marc Lombès, M.E. Rafestin-Oblin, Jérôme Fagart

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    A new oral therapy for long QT syndrome

    A new oral therapy for long QT syndrome by Susan P. Etheridge, Steven J. Compton, Martin Tristani‐Firouzi, Jay W. Mason

    Published 2003
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Clinical Use of Diuretics in Heart Failure, Cirrhosis, and Nephrotic Syndrome

    Clinical Use of Diuretics in Heart Failure, Cirrhosis, and Nephrotic Syndrome by Ahmed Hassaan Qavi, Rida Kamal, Robert W. Schrier

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    Eplerenone for hypertension

    Eplerenone for hypertension by Tina SC Tam, May Wu, Sarah Masson, Matthew P Tsang, Sarah Stabler, Angus Kinkade, Anthony Tung, Aaron M Tejani

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study‐Heart Failure (ARTS‐HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney disease

    Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study‐Heart Failure (ARTS‐HF): a randomized study of finerenone vs. eplerenone in patients who have worse... by Bertram Pitt, Stefan D. Anker, Michael Böhm, Mihai Gheorghiade, Lars Køber, Henry Krum, Aldo P. Maggioni, Piotr Ponikowski, Adriaan A. Voors, Faı̈ez Zannad, Christina Nowack, So‐Young Kim, Alexander Pieper, Nina Kimmeskamp‐Kirschbaum, Gerasimos Filippatos

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Incidence and Predictors of Hyperkalemia in Patients With Heart Failure

    Incidence and Predictors of Hyperkalemia in Patients With Heart Failure by Akshay S. Desai, Karl Swedberg, John J.V. McMurray, Christopher B. Granger, Salim Yusuf, James B. Young, Mark E. Dunlap, Scott D. Solomon, James W. Hainer, Bertil Olofsson, Eric L. Michelson, Marc A. Pfeffer

    Published 2007
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Spironolactone reduces blood pressure and albuminuria of obese hypertensive patients with Metabolic Syndrome

    Spironolactone reduces blood pressure and albuminuria of obese hypertensive patients with Metabolic Syndrome by Danielle Guedes Andrade Ezequiel, Rogério Baumgratz de Paula, Júlio César Moraes Lovisi, Thaís Chehuen Bicalho, Sergio Franca de Souza Filho, Sarah de Paula Iennaco de Rezende, Mônica Barros Costa

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Oral mineralocorticoid antagonists for recalcitrant central serous chorioretinopathy

    Oral mineralocorticoid antagonists for recalcitrant central serous chorioretinopathy by Eric K. Chin, David R.P. Almeida, C. Nathaniel Roybal, Philip Niles, Karen M. Gehrs, Elliott H. Sohn, H. Culver Boldt, Stephen R. Russell, James C. Folk

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Fracture Risk in Men With Congestive Heart Failure

    Fracture Risk in Men With Congestive Heart Failure by Laura Carbone, Jessica D. Cross, Syed Hasan Raza, Andrew Bush, Robert J. Sepanski, Saurabh S. Dhawan, Bilal Khan, Malini Gupta, Khurram Ahmad, Rami N. Khouzam, Dwight A. Dishmon, Joseph P. Nesheiwat, Mohammad Hajjar, Waqas Chishti, Wael Nasser, Mehwish Khan, Catherine Womack, Tara Cho, Ashley R. Haskin, Karl T. Weber

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites

    Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites by Pere Ginès, Vicente Arroyo, Enrique Quintero, Ramón Planas, Felipe Bory, Juan J. Cabrera, Antoni Rimola, Josep Maria Viver, Jordi Camps, Wladimiro Jiménez, Ricardo Mastaï, Joan Gaya, Joan Rodés

    Published 1987
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Refractory Hypertension: Definition, Prevalence, and Patient Characteristics

    Refractory Hypertension: Definition, Prevalence, and Patient Characteristics by Maria Czarina Acelajado, Roberto Pisoni, Tanja Dudenbostel, Louis J. Dell’Italia, Falynn Cartmill, Bin Zhang, Stacey S. Cofield, Suzanne Oparil, David A. Calhoun

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Factors associated with 30-day readmission of patients with heart failure from a Japanese administrative database

    Factors associated with 30-day readmission of patients with heart failure from a Japanese administrative database by Hiroki Aizawa, Shinobu Imai, Kiyohide Fushimi

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Mineralocorticoid receptors are present in skeletal muscle and represent a potential therapeutic target

    Mineralocorticoid receptors are present in skeletal muscle and represent a potential therapeutic target by Jessica Chadwick, J. Spencer Hauck, Jeovanna Lowe, Jeremiah J. Shaw, Denis C. Guttridge, Celso E. Gómez-Sánchez, Elise P. Gómez-Sánchez, Jill A. Rafael‐Fortney

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: